CDKN2B-AS1 and preeclampsia: The initial objective of our study is to evaluate for the first time the expression profiles of lncRNA ANRIL, its target miRNAs (miR-186, miR-181a), and MTMR-3 (target gene for miR-181a) in preeclampsia patients.